Trial Profile
Phase I trial of radezolid, an Rx 01 antibacterial for treating resistant infections
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 May 2014
Price :
$35
*
At a glance
- Drugs Radezolid (Primary)
- Indications Gram-positive infections; Nosocomial infections
- Focus Adverse reactions
- 24 Jan 2006 New trial record.